Starpharma Holdings Limited · ASX:SPL
Starpharma — Merger or Acquisition (June 2017)
12 slides from Starpharma's merger presentation, Jun 14, 2017
Slide 1: Sale of Agrochemicals Business Investor Presentation
For personal use only Sale of Agrochemicals Business Investor Presentation Melbourne, Australia; 14 June 2017: Starpharma Holdings Limited (ASX: SPL, OTCQX: SPHRY), will be holding an investor conference call today at 11am (AEST) to discuss the sale of its Agrochemicals business to Agrium Inc., for
Slide 2: Forward Looking Statements
cancer types including breast, prostate, lung and ovarian tumour, when compared to Taxotere® (docetaxel). In the partnered area, AstraZeneca has signed a licensing agreement with Starpharma for the use of its DEP® drug delivery platform in the development and commercialisation of a number of AstraZe
Slide 3: Sale of Starpharma Agrochemicals to Agrium Inc.
For personal use only ASX:SPL; OTCQX: SPHRY Sale of Starpharma Agrochemicals to Agrium Inc. June 2017
Slide 4: Forward Looking Statements
For personal use only This document contains certain forward-looking statements, relating to Starpharma’s business, which can be identified by the use of forward-looking terminology such as “promising”, “plans”, “anticipated”, “will”, “project”, “believe”, “forecast”, “expected”, “estimated”, “targe
Slide 5: Sale of Starpharma Agrochemicals
Sale of Starpharma Agrochemicals For personal use only Amount A$35M in cash consideration • Agrium Inc. (NYSE:AGU, TSE: AGU) Market Cap ~US$13B Purchaser • Annual revenues ~ US$14B p.a. • Global reach: 1,500 Ag-retail outlets and 15,200 staff • Starpharma Agrochemicals comprises key Priostar® patent
Slide 6: Agrium: A global leader in Agricultural Products
Agrium: A global leader in Agricultural Products For personal use only Leading global producer and distributor of agricultural products Listed on NYSE:AGU and TSX:AGU ~US$13B market cap Annual revenue ~US$14B 1,500 ag-retail centres; >15,200 employees globally Major producer of seed treatment, plant
Slide 7: Agrium: A global leader in Agricultural Products
Agrium: A global leader in Agricultural Products For personal use only “This acquisition represents an exciting strategic technology platform for Loveland Products that will serve to further differentiate our proprietary product line and open new product development partnership opportunities. Agrium
Slide 8: Transaction completed for $35M cash
Transaction completed for $35M cash For personal use only Starpharma Transaction has closed Holdings Limited • $35M cash consideration received (ASX:SPL) • Global process undertaken with Macquarie • Extensive due diligence completed • No conditions precedent Starpharma Pty Ltd • No FIRB Australian s
Slide 9: Pre-transaction: Starpharma's portfolio
Pre-transaction: Starpharma’s portfolio For personal use only Starpharma’s Dendrimer Platform ~120 granted patents ~104 granted patents ~16 granted patents VivaGel® Portfolio DEP® Drug Delivery Agrochemicals VivaGel® BV VivaGel® Internal DEP® Partnered DEP® Internal Priostar® Partnered Priostar® (ba
Slide 10: Post-transaction: Starpharma's portfolio
Post-transaction: Starpharma’s portfolio For personal use only • The transaction focuses Starpharma’s strategy on maximising the potential of its core pharmaceutical programs VivaGel® and DEP® • Transaction has no impact on VivaGel® or DEP® IP Starpharma’s Dendrimer Platform ~104 granted patents >$6
Slide 11: VivaGel and DEP: Significant Market Opportunities
VivaGel® and DEP®: Significant Market Opportunities For personal use only VivaGel® Portfolio DEP® Drug Delivery Portfolio • AstraZeneca deal: • first product est. US$450M AstraZeneca deal: (US$126M + royalties) • first product est. US$450M • BV• treatment subsequentmarket est. >US$750M products US$9
Slide 12: Starpharma contact details
For personal use only Starpharma: Media: Dr Jackie Fairley, Chief Executive Officer WE Buchan Consulting Nigel Baade, CFO and Company Secretary Rebecca Wilson Mob: +61 417 382 391 +61 3 8532 2704 rwilson@buchanwe.com.au investor.relations@starpharma.com www.starpharma.com PAGE 9
Starpharma Holdings — Merger or Acquisition (June 2017) on 6ix